1. KaloBios short sellers facing squeeze as CEO Shkreli says will no longer lend stock - MarketWatch. $NVGN shld do same http://www.marketwatch.com/story/kalobios-short-sellers-facing-squeeze-as-ceo-shkreli-says-will-no-longer-lend-stock-2015-11-27

  2. $NVGN Underlying strength seems to be back.

  3. $GENE Wow, congrats to longs who held. Been a good week for GENE. $NVGN take note.

  4. Watchlist $ibio $lptn $mack $meip $nvdq $nvgn $pbmd $petx $vvus $vicl $srne $opxa $ocul $ontx $ogen $ocul

  5. $NVGN Does it seem like there is a concerted effort to keep or push this stock down? Heading to Phase 1 Clinic trials should not drop price.

  6. $GENE amazing....$NVGN ww

  7. $NVGN Institutional ownership up 32.36% Q/Q, with 202,402 net purchase http://lovelystocks.com/NVGN

  8. Report of foreign issuer [Rules 13a-16 and 15d-16] http://www.conferencecalltranscripts.org/no/summary/?id=2217470 $NVGN

  9. $NVGN didn t move like we had hoped today but maybe we ll build momentum

  10. Best stocks under $10 (Nov 24) : $PER, $PKD, $TESO, $MVC, $CIDM, $NVGN http://www.stock1010.com/quote.php?symbol=PER

  11. The Company expected to receive the final report in early 2016 once a comprehensive pathology review was completed. $NVGN

  12. on track to complete the in-life phase of the toxicity studies by the end of 2015. $NVGN

  13. $NVGN said it was continuing to progress Cantrixil through the necessary preclinical regulatory requirements and safety evaluations and was

  14. malignant ascites, including ovarian cancer. $NVGN

  15. Cantrixil Phase 1 clinical trial to be conducted in patients with refractory/recurrent peritoneal malignancies with ... $NVGN

  16. Novogen engages Novotech as CRO for upcoming Phase 1 clinical study $NVGN

  17. $cali $tbio $xoma $prsn $dcth $amda $rloc $io $nvgn - You can t lie when your subscribers are also ST members.


  19. Not a crazy selection but here is the stocks that im watching today $CANF $SUNE $AVP $ABIO $SYN $MCUR $GENE $XRX $NVGN $AEZS

  20. Premarket Top % Gainers: $AEZS 30%, $NVGN 20%, $EDUC 11%, $ABIO 10%, $RUSS 9% $SUNE $BDBD $DGAZ $AUY $BZUN $TVIX $FRO $UVXY $OPXA $AVP $NUGT

  21. Premarket Top % Gainers: $AEZS 35%, $NVGN 20%, $ABIO 10%, $BDBD 8%, $RUSS $DGAZ $SUNE $EDUC $AUY $BZUN $OPXA $TVIX $FRO $UVXY $AVP $JNUG


  23. Premarket Top % Gainers: $AEZS 37%, $NVGN 20%, $ABIO 11%, $BDBD 8%, $OPXA $SPHS $BZUN $RUSS $SUNE $EDUC $DGAZ $FRO

  24. Novogen Engages Contract Research Organisation to Conduct Cantrixil Phase 1 Clinical Trial $NVGN

  25. $NVGN Russian jet getting shot down may be a slight hamper.